IRVINE, CA--(Marketwire - March 22, 2011) -
Paragon Biomedical, a leader of global CRO solutions to the biopharmaceutical and medical device industries, today announced they have partnered with Medrio, an electronic data capture (EDC) software company, further adding to Paragon's expertise in managing EDC-driven clinical programs.
"Paragon has successfully worked with Medrio for more than two years, conducting numerous studies together," says Marianne Plaunt, Vice President, Global Project Services, which includes Paragon's data management, statistical, and medical writing services. "While Paragon will partner with any of its Sponsors' EDC providers and has, in fact, worked with all Top 5 EDC providers, Medrio's open and flexible system allows Paragon's rapid study start-up timeline to average 6 weeks compared to the industry average of 12 weeks. We are proud to say 100% of our data operations studies over the past three years have either locked early or on-time, including a recently completed 2,500 patient global trial where 300 case books were locked in four working days."
Mike Novotny, Chief Executive Officer of Medrio, adds, "Paragon has been a key partner in Medrio's growth and expansion. Paragon Biomedical's expertise with Medrio provides important efficiencies for Sponsors because Paragon provides a single point of contact for all services, which enables Medrio to focus on building great software. Results include faster build times, lower costs, and better implementation for sites."
Medrio provides a fully-hosted eClinical system that CROs or Sponsors configure without reliance on software programmers. The result is a vast improvement in 1) Deployment Time: studies online in days rather than weeks, and mid-study changes in hours; 2) Cost: low monthly subscription per study; and 3) Control: no dependence on staff from the eClinical vendor.
Medrio supports Phase I through IV trials within a secure, regulatory-compliant environment.
Please visit Medrio on the web at www.medrio.com.
About Paragon Biomedical
Paragon Biomedical is a global, full-service clinical research organization (CRO) providing Phase I through IV clinical research services and support to the world's biopharmaceutical and medical device companies.
Paragon is a woman-owned CRO certified by the National Women Business Owners Corporation (NWBOC) and the Women's Business Enterprise National Council (WBENC).
Please visit Paragon Biomedical on the web at www.paragonbiomedical.com.